Salman Khan Faces Legal Trouble Over Misleading Pan-Masala Ad; Kota Court Notice Issued

Mumbai, November 5 — Bollywood superstar Salman Khan is back in the headlines, this time due to a legal controversy over a pan-masala brand he endorses. The Kota Consumer Court has issued formal notices to both the actor and the company, citing allegations of misleading advertising. The next hearing is scheduled for November 27, 2025.
The issue has not only attracted attention because of Salman Khan’s celebrity status but also due to the larger concerns surrounding advertising ethics in India. In recent years, courts and regulatory bodies have been increasingly vigilant about claims made in advertisements, especially when they involve products that may affect public health. The involvement of a high-profile figure like Salman Khan has further amplified the matter, turning it into a national conversation about responsibility, trust, and the influence of celebrities.
This controversy also reflects the growing scrutiny faced by public figures who endorse products. While brand endorsements have always been a significant part of celebrity income, they now come with heightened accountability. Consumers today are more aware, and with social media amplifying every claim and counterclaim, even minor discrepancies can lead to major legal challenges.
The Complaint: Allegations of Misleading Advertising
The legal issue arose after a complaint was filed in the Kota Consumer Court. The petitioner claims that the pan-masala product endorsed by Salman Khan falsely advertises saffron content. Since saffron is a high-priced spice, the allegation is that the low-cost packets cannot realistically contain the premium ingredient.
The complaint also highlights the influence of celebrity endorsements, arguing that Salman Khan’s promotion could mislead young consumers into thinking the product is of superior quality or safe to consume. Pan-masala is widely known to carry serious health risks, including oral cancer and other medical complications.
Expanding on the complaint, the petitioner has reportedly questioned the scientific and economic feasibility of including genuine saffron in a product that is sold at a relatively low price point. Saffron is one of the most expensive spices in the world, often referred to as “red gold,” and its inclusion in inexpensive consumer goods raises doubts about authenticity. This has led to speculation that the claim may be exaggerated or purely promotional in nature.
Another key concern raised in the complaint is the psychological impact of celebrity endorsements. When a widely recognized figure promotes a product, it often creates an impression of trust and credibility. For many consumers, especially younger audiences, the presence of a celebrity in an advertisement can act as a form of assurance regarding the product’s quality and safety. The complainant argues that this trust can be misused if the claims made in the advertisement are not entirely accurate.
Furthermore, the complaint touches upon the ethical dimension of promoting products that may have adverse health effects. Pan-masala consumption has long been associated with health hazards, and critics argue that endorsing such products indirectly encourages their use. This aspect has added a moral layer to the legal argument, making the case more than just a matter of false advertising.
Legal Proceedings and Court Notice
Following the complaint, the Kota Consumer Court issued notices to Salman Khan and the pan-masala company, asking them to respond. The court stressed that celebrity endorsers share responsibility in ensuring product claims are truthful and not misleading.
The next hearing, set for November 27, 2025, will review responses from both the actor and the company, determining the next steps in the case.
Legal experts suggest that the court may examine multiple aspects before arriving at a conclusion. This could include reviewing the advertisement content, analyzing product composition, and assessing whether the claims made are supported by verifiable evidence. If discrepancies are found, the court could order corrective measures such as withdrawing the advertisement or issuing clarifications to consumers.
The role of consumer courts in India has evolved significantly over the years. These courts are designed to protect consumer rights and ensure that companies do not engage in unfair trade practices. In cases involving misleading advertisements, the courts often take a strict stance to discourage such practices and uphold transparency in the market.
Another important factor in this case is the precedent it may set. If the court rules against the endorsement, it could lead to stricter guidelines for celebrity advertising. Brands may be required to provide more detailed disclosures, and celebrities might need to conduct thorough due diligence before associating with a product.
Implications for Salman Khan
While Salman Khan has faced legal challenges in the past, this case is focused on advertising ethics and consumer protection. Courts are increasingly holding celebrity endorsers accountable for promoting products that may be misleading or harmful.
Key questions raised include:
- Can the product genuinely contain saffron at such a low cost?
- What responsibility does Salman Khan have in endorsing this product?
Legal experts note that endorsers can face consequences if it is proven they promoted a misleading claim knowingly or negligently.
For Salman Khan, the case could have broader implications beyond the courtroom. As one of India’s most influential celebrities, his brand image plays a crucial role in his career. Endorsements form a significant part of his professional portfolio, and controversies like this can affect public perception.
There is also the aspect of contractual obligations. Celebrities often sign endorsement deals based on information provided by the brand. If the claims made by the company are found to be inaccurate, the responsibility may shift toward the manufacturer. However, if it is proven that the endorser failed to verify the claims adequately, they could also be held liable.
This situation also highlights the need for celebrities to be more cautious when selecting endorsement deals. With increasing legal scrutiny, endorsers are expected to exercise due diligence and ensure that the products they promote meet regulatory standards. This includes verifying claims, understanding product composition, and being aware of potential risks associated with the product.
Perspectives: Complainant vs. Defense
Complainant’s Perspective:
- Salman Khan, as a role model, has a responsibility to avoid promoting misleading or harmful products.
- Celebrity endorsements may influence youth and encourage the consumption of risky products like pan-masala.
Potential Defense:
- The advertisement may comply with regulations.
- The saffron claim might be symbolic or minimal.
- Product labeling and disclaimers could meet legal requirements.
Currently, neither Salman Khan nor the brand has publicly commented on the court notice.
From a legal standpoint, the defense may argue that advertisements often use creative language and symbolic representation. In many cases, terms like “saffron flavor” or “saffron essence” are used rather than implying the presence of pure saffron. If such distinctions are clearly mentioned in the product labeling, the company may claim compliance with advertising standards.
Additionally, the defense could point out that consumers are expected to exercise reasonable judgment while purchasing products. Advertisements are meant to attract attention and are not always literal representations of the product. This argument has been used in several past cases to justify exaggerated claims in marketing.
On the other hand, the complainant may emphasize that when health-related products are involved, even minor exaggerations can have serious consequences. The use of premium ingredients as a selling point can create unrealistic expectations and potentially mislead consumers.
Broader Implications: Advertising, Health, and Celebrity Endorsements
This case sheds light on wider concerns in India’s advertising industry:
- Celebrity Responsibility: Consumers often trust products based on a star’s endorsement, making accuracy crucial.
- Consumer Protection: Misleading claims can lead to legal consequences, emphasizing transparency in marketing.
- Health Concerns: Pan-masala poses serious health risks; ethical promotion is vital, especially when youth are exposed.
- Regulatory Oversight: Consumer courts play an important role in ensuring ethical advertising and safeguarding public health.
In recent years, regulatory bodies such as the Advertising Standards Council of India (ASCI) have introduced guidelines to ensure that advertisements are not misleading. These guidelines also require celebrities to verify the claims made by brands before endorsing them. Failure to do so can result in penalties and legal action.
The growing awareness among consumers has also played a significant role in shaping the advertising landscape. People are now more likely to question claims and seek evidence before trusting a product. Social media platforms have become powerful tools for raising concerns and holding brands accountable.
Another important aspect is the ethical responsibility of promoting products that may have adverse health effects. With increasing awareness about lifestyle diseases, there is a growing demand for responsible advertising. Celebrities, given their influence, are expected to set an example by endorsing products that align with public health and safety.
What to Watch Ahead
The November 27 hearing will be key in determining the case’s direction. Observers will watch for:
- Written defenses from Salman Khan or the pan-masala company
- Evidence proving or disproving saffron content
- Interim court directives such as ad withdrawal or consumer clarifications
Experts suggest the outcome could impact how celebrity endorsements are managed in India, pushing brands and celebrities to ensure all claims are accurate and verifiable.
Another crucial aspect to watch will be the court’s interpretation of responsibility. If the ruling emphasizes the accountability of endorsers, it could lead to a shift in how endorsement contracts are structured. Celebrities may demand more transparency from brands, and legal teams may play a bigger role in evaluating endorsement deals.
The case may also influence future advertising campaigns. Companies might adopt more cautious language and avoid making claims that could be challenged legally. This could lead to a more transparent and consumer-friendly advertising environment.
Conclusion
Salman Khan’s involvement highlights the growing accountability of celebrities in product endorsements. While his star power can elevate a brand, it does not exempt him from consumer protection laws. The upcoming court hearing will provide more clarity, but this case already serves as a reminder that ethical advertising and public responsibility are essential in India’s consumer market.





